Janus Henderson Group
ROIV icon

Janus Henderson Group’s Roivant Sciences ROIV Stock Holding History

Janus Henderson Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.8M Buy
3,095,448
+177,339
+6% +$4.56M 0.04% 308
2025
Q4 		$63.3M Buy
2,918,109
+2,775,331
+1,944% +$54.8M 0.03% 371
2025
Q3 		$2.16M Sell
142,778
-17,665
-11% -$219K ﹤0.01% 1300
2025
Q2 		$1.81M Hold
160,443
– – ﹤0.01% 1333
2025
Q1 		$1.66M Sell
160,443
-14,700
-8% -$159K ﹤0.01% 1373
2024
Q4 		$2.07M Hold
175,143
– – ﹤0.01% 1291
2024
Q3 		$2.02M Hold
175,143
– – ﹤0.01% 1309
2024
Q2 		$1.85M Buy
175,143
+48,200
+38% +$528K ﹤0.01% 1294
2024
Q1 		$1.34M Sell
126,943
-24
-0% -$259 ﹤0.01% 1488
2023
Q4 		$1.43M Sell
126,967
-3,851,530
-97% -$37.5M ﹤0.01% 1434
2023
Q3 		$46.5M Sell
3,978,497
-470,924
-11% -$5.32M 0.03% 373
2023
Q2 		$44.9M Sell
4,449,421
-312,017
-7% -$2.79M 0.03% 408
2023
Q1 		$35.1M Buy
4,761,438
+4,714,774
+10,104% +$38.8M 0.02% 458
2022
Q4 		$373K Hold
46,664
– – ﹤0.01% 1865
2022
Q3 		$150K Sell
46,664
-21,203
-31% -$82.1K ﹤0.01% 1960
2022
Q2 		$277K Buy
+67,867
New +$269K ﹤0.01% 2124

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janus Henderson Group's ROIV Position: Q1 2026 in Review

Janus Henderson Group increased its Roivant Sciences (ROIV) stake by 6.1% in Q1 2026, buying an estimated $4.56M and bringing the position to 3,095,448 shares worth $85.8M. The position accounts for 0.04% of the portfolio, ranked #308.

Janus Henderson Group first reported a position in ROIV in Q2 2022 and has held it in 16 quarters since. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Janus Henderson Group held 3,095,448 shares of Roivant Sciences worth $85.8M as of Q1 2026.
  • Janus Henderson Group bought 177,339 Roivant Sciences shares in Q1 2026, an estimated $4.56M.
  • Roivant Sciences made up 0.04% of Janus Henderson Group's portfolio in Q1 2026, its #308 holding.
  • Janus Henderson Group first reported a position in Roivant Sciences in Q2 2022 and has held it in 16 quarters since.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.